BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35713228)

  • 41. Cancer stem cell characteristics and their potential as therapeutic targets.
    Lim JR; Mouawad J; Gorton OK; Bubb WA; Kwan AH
    Med Oncol; 2021 May; 38(7):76. PubMed ID: 34050825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cancer stem cells in tumor heterogeneity and resistance to therapy.
    Konrad CV; Murali R; Varghese BA; Nair R
    Can J Physiol Pharmacol; 2017 Jan; 95(1):1-15. PubMed ID: 27925473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
    Fessler E; Dijkgraaf FE; De Sousa E Melo F; Medema JP
    Cancer Lett; 2013 Nov; 341(1):97-104. PubMed ID: 23089245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of cancer stem cells in relapse of solid tumors.
    Yu Y; Ramena G; Elble RC
    Front Biosci (Elite Ed); 2012 Jan; 4(4):1528-41. PubMed ID: 22201973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer stem cells and tumor metastasis (Review).
    Li S; Li Q
    Int J Oncol; 2014 Jun; 44(6):1806-12. PubMed ID: 24691919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
    Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
    Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
    Ryoo IG; Lee SH; Kwak MK
    Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The implications of cancer stem cells for cancer therapy.
    Jiang W; Peng J; Zhang Y; Cho WC; Jin K
    Int J Mol Sci; 2012 Dec; 13(12):16636-57. PubMed ID: 23443123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer stem cells: a new framework for the design of tumor therapies.
    Garvalov BK; Acker T
    J Mol Med (Berl); 2011 Feb; 89(2):95-107. PubMed ID: 20890588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer Stem Cells: Concepts, Challenges, and Opportunities for Cancer Therapy.
    Lee MY; Giraddi RR; Tam WL
    Methods Mol Biol; 2019; 2005():43-66. PubMed ID: 31175645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.
    Ma Z; Wang YY; Xin HW; Wang L; Arfuso F; Dharmarajan A; Kumar AP; Wang H; Tang FR; Warrier S; Tergaonkar V; Sethi G
    Int J Biochem Cell Biol; 2019 Mar; 108():17-20. PubMed ID: 30630112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
    Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
    Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The emerging role of lncRNAs in the regulation of cancer stem cells.
    Castro-Oropeza R; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K
    Cell Oncol (Dordr); 2018 Dec; 41(6):585-603. PubMed ID: 30218296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer Stem Cells and Stem Cell Tumors in Drosophila.
    Singh SR; Aggarwal P; Hou SX
    Adv Exp Med Biol; 2019; 1167():175-190. PubMed ID: 31520355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.
    Barkeer S; Chugh S; Batra SK; Ponnusamy MP
    Neoplasia; 2018 Aug; 20(8):813-825. PubMed ID: 30015157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.